会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Process for the preparation of 5-substituted resorcinols and related
intermediates
    • 5-取代的间苯二酚和相关中间体的制备方法
    • US4249027A
    • 1981-02-03
    • US737377
    • 1976-11-01
    • Jacques Gosteli
    • Jacques Gosteli
    • C07C69/88C07C37/50C07C39/08C07C51/09C07C39/12
    • C07C51/09C07C37/50
    • According to the present invention, 5-substituted resorcinols of the formula I ##STR1## wherein R.sub.1 represents a hydrocarbon radical, optionally unsubstituted or substituted by inert substituents, are prepared by reacting a carboxylic acid ester of the formula IIR.sub.1 --C.tbd.C--CO--O--R.sub.2 (II)wherein R.sub.2 represents a non-aromatically bound lower hydrocarbon radical, in the presence of an alkaline condensation agent, with a diester of 3-oxoglutaric acid of the formula IIIR.sub.3 --O--CO--CH.sub.2 --CO--CH.sub.2 --CO--O--R.sub.4 (III)wherein R.sub.3 and R.sub.4 represent non-aromatically bound lower hydrocarbon radicals; hydrolyzing the resulting dihydroxyisophthalic acid acid ester of the formula IV ##STR2## and decarboxylating the hydrolyzed product, a specific embodiment is the preparation of 5-pentylresorcinol.
    • 根据本发明,式I的5-取代的间苯二酚(I)其中R 1表示任选未被取代或被惰性取代基取代的烃基,通过使式II的羧酸酯R1-C 其中R 2表示非芳香结合的低级烃基,在碱性缩合剂的存在下,与式III的3-氧代戊二酸的二酯R 3 -O-CO- CH2-CO-CH2-CO-O-R4(Ⅲ)其中R3和R4代表非芳香结合的低级烃基; 水解所得的式IV(IV)的二羟基间苯二酸酸酯并使水解产物脱羧,具体实施方案是5-戊基间苯二酚的制备。
    • 6. 发明授权
    • Process for the manufacture of indigoid dyes
    • 靛蓝染料的制造方法
    • US4151170A
    • 1979-04-24
    • US751223
    • 1976-12-16
    • Jacques Gosteli
    • Jacques Gosteli
    • C09B7/00C07C67/00C07C201/00C07C205/45C09B7/02D06P1/28D06P3/60
    • C09B7/02
    • A process for the manufacture of indigoid dyes, wherein a functional derivative of the anthranilic acid of the general formula I ##STR1## in which A completes a mono- or polynuclear, substituted or unsubstituted aromatic ring,X represents a hydrogen atom or a protective group for the free amino group which can form an anhydro derivative with the carboxyl group in the ortho-position,Is reacted with nitromethane in the presence of a base or with a salt of nitroacetic acid to give the .omega.-nitro-o-amino-acetophenone derivative of the general formula II ##STR2## in which A and X are as defined in formula I, and this intermediate is condensed by heating with acids to give the indigo compound of the general formula III ##STR3## in which A is as defined in formula I.
    • 靛蓝染料的制备方法,其中通式Ⅰ的邻氨基苯甲酸的功能性衍生物(I)其中A完成单或多核,取代或未取代的芳环,X表示氢原子或 可以在邻位形成具有羧基的脱水衍生物的游离氨基的保护基,在碱存在或与硝酸盐存在下与硝基甲苯反应以产生ω-NITRO-O- 其中A和X如式I所定义的通式II(II)的氨基 - 乙炔酮衍生物,并且该中间体通过与酸加热而缩合,得到通式III的靛蓝化合物(IMAGE)( III)其中A如式I所定义。
    • 7. 发明授权
    • 2-Penem compounds
    • 2-Penem化合物
    • US4070477A
    • 1978-01-24
    • US746979
    • 1976-12-02
    • Ivan ErnestJacques GosteliRobert Burns Woodward
    • Ivan ErnestJacques GosteliRobert Burns Woodward
    • C07D499/04A61K31/397A61K31/43A61P31/04C07D205/08C07D205/095C07D403/04C07D499/21C07D499/44C07D499/88C07F9/568A61K31/425C07D499/02
    • C07D499/88C07D205/095C07F9/5683Y02P20/55
    • The invention relates to 6-amino-2-penem-3-carboxylic acid compounds of the formula ##STR1## in which R.sub.1.sup.a denotes hydrogen or an amino protective group R.sub.1.sup.A and R.sub.1.sup.b represents hydrogen or an acyl radical Ac, or in which R.sub.1.sup.a and R.sub.1.sup.b conjointly form a bivalent amino protective group, R.sub.2 denotes hydroxyl or a radical R.sub.2.sup.A which, together with the carbonyl grouping --C(.dbd.0)--, forms a protected carboxyl group, and R.sub.3 represents hydrogen or an organic radical which is linked via a carbon atom to the ring carbon atom, and 1-oxides thereof, as well as salts of such compounds having salt-forming groups, which compounds possess antibiotic properties, processes for the manufacture of such compounds, and also pharmaceutical formulations containing compounds of the formula I with pharmacological properties, and the use thereof, either as antibiotics, preferably in the form of pharmaceutical formulations, or as intermediate products.
    • 本发明涉及式(I)的6-氨基-2-青霉烯-3-羧酸化合物,其中R 1a表示氢或氨基保护基R 1A和R 1b表示氢或酰基Ac,或其中 R1a和R1b共同形成二价氨基保护基,R2表示羟基或R2A基团,与羰基-C(= O)一起形成保护的羧基,R3表示氢或连接的有机基团 通过碳原子与环碳原子及其1-氧化物,以及具有成盐基团的化合物的盐,该化合物具有抗生素性质,制备这些化合物的方法,以及含有化合物的化合物的药物制剂 具有药理学性质的式I及其用途,优选为药物制剂形式的抗生素或作为中间产物。
    • 8. 发明授权
    • Process for the preparation of 2-substituted
5-chloroimidazole-4-carbaldehydes
    • 2-取代的5-氯咪唑-4-甲醛的制备方法
    • US5536841A
    • 1996-07-16
    • US492444
    • 1995-06-19
    • Gareth GriffithsRene ImwinkelriedJacques Gosteli
    • Gareth GriffithsRene ImwinkelriedJacques Gosteli
    • C07D233/68C07D233/70C07D233/96C07D233/32
    • C07D233/96C07D233/68
    • A process for preparing 2-substituted 5-chloroimidazole-4-carbaldehydes of the general formula: ##STR1## In the process, a glycine ester hydrohalide is ring-closed with an imidate ester to obtain the intermediate 2-substituted 3,5-dihydroimidazol-4-one. This intermediate is converted with an N,N-substituted formamide acetel into an N,N-substituted aminomethyleneimidazolinone. This latter intermediate is chlorinated with phosphorus oxychloride or phosgene to obtain the final product 2-substituted 5-chlorimidazole-4-carbaldehydes of the general formula I.Also disclosed are N,N-substituted aminomethyleneimidazolinones of the general formula: ##STR2## wherein R is hydrogen or is an alkyl group, an alkenyl group, a cycloalkyl group, an arylalkyl group or an aryl group, and R.sub.5 and R.sub.6 are identical or different and each is an alkyl group or an aryl group, in the form of the E- or Z-isomer.
    • 制备以下通式的2-取代的5-氯咪唑-4-甲醛的方法:在该方法中,甘氨酸酯氢卤化物与亚氨酸酯酯闭环,得到中间体2-取代的3,5-二 二氢咪唑-4-酮。 该中间体用N,N-取代的甲酰胺乙缩醛转化成N,N-取代的氨基亚甲基咪唑啉酮。 将后一中间体用磷酰氯或光气氯化,得到通式I的最终产物2-取代的5-氯咪唑-4-甲醛。还公开了通式如下的N,N-取代的氨基亚甲基咪唑啉酮其中 R是氢或是烷基,烯基,环烷基,芳基烷基或芳基,R 5和R 6相同或不同,各自为烷基或芳基,其形式为E - 或Z-异构体。
    • 9. 发明授权
    • Process for the preparation of 2-substituted
5-chloroimidazole-4-carbaldehydes
    • 2-取代的5-氯咪唑-4-甲醛的制备方法
    • US5486617A
    • 1996-01-23
    • US340377
    • 1994-11-14
    • Gareth GriffithsRene ImwinkelriedJacques Gosteli
    • Gareth GriffithsRene ImwinkelriedJacques Gosteli
    • C07D233/68C07D233/70C07D233/96
    • C07D233/96C07D233/68
    • A process for preparing 2-substituted 5-chloroimidazole-4-carbaldehydes of the general formula: ##STR1## In the process, a glycine ester hydrohalide is ring-closed with an imidate ester to obtain the intermediate 2-substituted 3,5-dihydroimidazol-4-one. This intermediate is converted with an N,N-substituted formamide acetal into an N,N-substituted aminomethyleneimidazolinone. This latter intermediate is chlorinated with phosphorus oxychloride or phosgene to obtain the final product 2-substituted 5-chlorimidazole-4-carbaldehydes of the general formula I.Also disclosed are N,N-substituted aminomethyleneimidazolinones of the general formula: ##STR2## wherein R is hydrogen or is an alkyl group, an alkenyl group, a cycloalkyl group, an arylalkyl group or an aryl group, and R.sub.5 and R.sub.6 are identical or different and each is an alkyl group or an aryl group, in the form of the E- or Z-isomer.
    • 制备以下通式的2-取代的5-氯咪唑-4-甲醛的方法:在该方法中,甘氨酸酯氢卤化物与亚氨酸酯酯闭环,得到中间体2-取代的3,5-二 二氢咪唑-4-酮。 该中间体用N,N-取代的甲酰胺缩醛转化成N,N-取代的氨基亚甲基咪唑啉酮。 将后一中间体用磷酰氯或光气氯化,得到通式I的最终产物2-取代的5-氯咪唑-4-甲醛。还公开了通式如下的N,N-取代的氨基亚甲基咪唑啉酮其中 R是氢或是烷基,烯基,环烷基,芳基烷基或芳基,R 5和R 6相同或不同,各自是烷基或芳基,其形式为E - 或Z-异构体。